Brought to you by 
ArQule completes $70.87mm follow-on offering
06 Jun 2001
Executive Summary
Small-molecule synthesis and optimization company ArQule sold 3.36mm common shares at $22.50 apiece in a follow-on public offering (including the 438k-share overallotment), netting about $70.87mm. The company increased the number of shares from its original October filing of 2.5mm shares.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ArQule completes $70.87mm follow-on offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice